Peter Alterman Named COO, SAFE-BioPharma Association

Pharma IQ News

Peter AltermanNamed COO, SAFE-BioPharma Association

Peter Alterman, Ph.D., who held numerous senior information security positions within the U.S. federal government, has been named Chief Operating Officer of SAFE-BioPharma Association, the strategic, non-profit collaboration responsible for the global SAFE-BioPharma® digital identity and digital signature standard used in the life science and healthcare sectors. The association’s members include the world’s largest biopharmaceutical companies and many life science and healthcare organizations.

Dr. Alterman recently retired after 33 years of government service where, most recently, he was Senior Advisor to the National Program Office of the National Strategy for Trusted Identities in Cyberspace (NSTIC), NIST. Before that he served as Senior Advisor to the NIH CIO for Strategic Initiatives, Assistant CIO for e-authentication at the National Institutes of Health and Chair of the U.S. Federal PKI Policy Authority. His role in Internet technology started in 1989 as a member of the Federal Research Internet Coordinating Committee.

“Peter is highly regarded for his work in government, where he played a major role in establishing the Federal PKI Policy Authority. His many working relationships and extensive management experience will help the association respond to the growing use of the SAFE-BioPharma standard as government and industry move their business interactions to the cloud,” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association.

In addition to responsibilities for a variety of association management functions, Dr. Alterman will serve as SAFE-BioPharma’s primary liaison with the U.S. FDA and other global regulatory authorities and represent the association’s interests on global standards and policy bodies.


For more information on the SAFE-BioPharma standard for digital identity and digital signatures used in life science and healthcare settings, visit